Each year, during Match Day, medical students across the country find out where they'll be doing their residencies.
Category: Stanford Medicine
Breaking down diabetes: Insulin, unwelcome, but underutilized
In this Breaking Down Diabetes installment, physician-research Randall Stafford clarifies the pros and cons of insulin use in Type 2 diabetes.
Stanford researchers probe the ethics of using artificial intelligence in medicine
Physicians should consider the ethical challenges of using artificial intelligence in making patient care decisions, three Stanford University School of Medicine researchers say in a perspective piece in The New England Journal of Medicine.
Crying my way through a difficult patient encounter
In this piece, first-year medical student Orly Farber talks about controlling her emotions is a clinical setting.
“Brain balls” let scientists mimic, study neurodevelopmental disorders in a dish
The human brain, and how it works, is one of the great mysteries of science. If only you could grow a brain in a bottle, you could learn a lot about what can go wrong – or for that matter, what goes right – in early brain development. So that's why Sergiu Pasca did.
Stanford symposium illuminates how stem cell therapies interact with their surroundings
Reaping stem cells’ full therapeutic benefits requires a detailed understanding of the complex relationships between the cells and their environments -- whether in a lab dish or a patient’s body.
New imaging agent could help personalize lung cancer treatment
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
Why Frankenstein matters, now, to you
Stanford anesthesiologist and writer Audrey Shafer reflects on the importance of considering the scientific and ethical issues raised by Frankenstein.
Stanford Presence Center symposium grapples with balancing human and artificial intelligence in medicine
Stanford’s Abraham Verghese believes there should be a more nuanced conversation around what artificial intelligence can do for doctors.
Advanced cell-labeling technology identifies suspect cell type, possible new therapeutic approach to multiple sclerosis
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
Social media gives early clues to adverse drug reactions in cancer, Stanford researchers find
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
Celiac disease may have an “off” switch, new study suggests
Researchers have found a way to turn off a key driver of inflammation in celiac disease, an autoimmune disease that affects millions of Americans.
Coordinately altered protein/receptor combo could eliminate side effects of promising anti-cancer therapy
A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
A cheaper, faster, more reliable test for TB developed by Stanford researchers
Tuberculosis is a major public health problem worldwide, yet most people lack access to quick, reliable testing. Now, chemists have found a solution.
Pushing boundaries, Stanford researcher explores growing human organs in animals
Stanford researcher Hiromitsu Nakauchi explores his dream of growing custom-made, transplantable human organs in large animals, despite funding difficulties.
From hand-washing to cancer detection: Why the pace of medicine is just right
Should research findings be moved to the clinic as soon as possible or should things move more slowly for patient safety? A med student explores the issues.